Share-Based Payments - Schedule of parameters used in relation to the new grants (Details) |
1 Months Ended | 12 Months Ended | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2025
equityInstrument
yr
$ / shares
|
Sep. 30, 2025
yr
equityInstrument
$ / shares
|
Jun. 30, 2025
yr
equityInstrument
$ / shares
|
Mar. 31, 2025
equityInstrument
yr
$ / shares
|
Dec. 31, 2024
yr
equityInstrument
$ / shares
|
Sep. 30, 2024
yr
equityInstrument
$ / shares
|
Jun. 30, 2024
yr
equityInstrument
$ / shares
|
Apr. 30, 2024
equityInstrument
yr
$ / shares
|
Dec. 31, 2023
yr
equityInstrument
$ / shares
|
Oct. 31, 2023
equityInstrument
yr
$ / shares
|
Jul. 31, 2023
yr
equityInstrument
$ / shares
|
Apr. 30, 2023
yr
equityInstrument
$ / shares
|
Dec. 31, 2025
shares
$ / shares
|
Dec. 31, 2024
shares
$ / shares
|
Dec. 31, 2023
shares
$ / shares
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||||||||||
| Number of options granted (in shares) | 17,595 | 30,762 | 593,475 | 21,469 | 20,296 | 33,529 | 660,166 | 42,243 | 79,305 | 74,529 | 629,121 | 61,056 | 663,301 | 756,234 | 844,011 |
| Share price (in USD per share) | $ 842.24 | $ 620.43 | |||||||||||||
| Exercise price (in USD per share) | $ 837.78 | $ 717.61 | $ 561.74 | $ 596.99 | $ 618.56 | $ 535.95 | $ 445.76 | $ 396.30 | $ 329.26 | $ 485.01 | $ 387.35 | $ 370.34 | $ 837.78 | $ 618.56 | $ 329.26 |
| Average Expected option life (in years) | yr | 5.34 | ||||||||||||||
| Expected dividends (as percent) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |||
| Belgian taxed beneficiaries | |||||||||||||||
| Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||||||||||
| Number of options granted (in shares) | equityInstrument | 1,833 | ||||||||||||||
| Bottom of range | |||||||||||||||
| Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||||||||||
| Average fair value of options (in USD per share) | $ 324.22 | $ 249.21 | $ 177.33 | $ 147.95 | $ 170.44 | $ 188.85 | $ 158.50 | $ 112.14 | $ 161.88 | $ 123.94 | $ 176.44 | $ 158.21 | |||
| Share price (in USD per share) | $ 724.65 | $ 550.61 | $ 547.67 | $ 543.68 | $ 437.41 | $ 365.56 | $ 371.36 | $ 439.42 | $ 380.81 | $ 361.64 | |||||
| Expected volatility (as percent) | 38.22% | 33.16% | 30.54% | 32.61% | 31.55% | 33.33% | 35.17% | 35.53% | 36.21% | 35.35% | 36.22% | 41.00% | |||
| Average Expected option life (in years) | yr | 3.88 | 4.02 | 4.16 | 4.33 | 3.88 | 4.05 | 4.16 | 4.30 | 4.00 | 4.00 | 4.00 | 4.00 | |||
| Risk-free interest rate (as percent) | 2.35% | 2.09% | 2.02% | 1.91% | 1.97% | 2.06% | 2.48% | 2.66% | 2.40% | 2.80% | 2.90% | 2.96% | |||
| Bottom of range | Belgian taxed beneficiaries | |||||||||||||||
| Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||||||||||
| Time period for beneficiaries to choose contractual term (in years) | 5 years | 5 years | 5 years | ||||||||||||
| Share options granted (as percent) | 100.00% | ||||||||||||||
| Top of range | |||||||||||||||
| Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||||||||||
| Average fair value of options (in USD per share) | $ 446.49 | $ 308.47 | $ 194.55 | $ 220.99 | $ 298.99 | $ 215.16 | $ 156.49 | $ 200.55 | $ 209.04 | $ 271.59 | $ 196.18 | ||||
| Share price (in USD per share) | $ 918.62 | $ 707.89 | $ 584.66 | $ 656.53 | $ 492.86 | $ 396.30 | $ 403.77 | $ 491.75 | $ 521.19 | $ 401.21 | |||||
| Expected volatility (as percent) | 37.48% | 31.61% | 33.43% | 34.46% | 35.61% | 36.16% | 39.04% | 38.64% | 36.67% | 43.99% | 42.18% | ||||
| Average Expected option life (in years) | yr | 6.07 | 6.22 | 6.35 | 6.52 | 6.07 | 6.24 | 6.35 | 6.49 | 6.50 | 6.50 | 6.50 | 6.50 | |||
| Risk-free interest rate (as percent) | 2.26% | 2.37% | 2.43% | 2.25% | 2.24% | 2.87% | 3.02% | 2.81% | 3.44% | 3.03% | 3.14% | ||||
| Top of range | Belgian taxed beneficiaries | |||||||||||||||
| Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||||||||||
| Time period for beneficiaries to choose contractual term (in years) | 10 years | 10 years | 10 years | ||||||||||||